Welcome!

By: Andres Gomez-De Leon
Date: 26/03/2018
1150

Developing Hematology is a blog written for medical professionals who practice clinical hematology in developing countries

We aim to offer a practical insight, from the perspective of scientists working in low to middle-income countries, where most of the population of the entire world are actually living in.

Free from the shackles of formality which limit our written word to rigid scientific language in peer reviewed medical journals, this space offers sincere opinions from a variety of editorialists on current clinical hematology research.

With a focus on issues regarding resource optimization, diagnostic strategies and treatment availability, Developing Hematology hopes to become a useful reference for all professionals working in a restricted environment.

Source
Tags

Andres Gomez-De Leon

BMT fellow, DH editor. Universidad Autónoma de Nuevo León. Facultad de medicina y Hospital Universitario "Dr. José Eleuterio González" Monterrey, Mexico. Contact: drgomezdeleon@gmail.com

Related Articles

16/07/2018
Can we change the dismal future of relapsed AML patients?

While acute myeloid leukemia (AML) patients have a chance for long-term remission and cure, some of them will not attain

Read More
09/04/2018
The changing landscape of mantle cell lymphoma.

Mantle cell lymphoma (MCL) is a B-cell malignancy with an inferior prognosis in comparison to other lymphomas. Most patients present

Read More
09/04/2018
How I treat multiple myeloma when resources are scarce.

dexamethasone and adriamycin. Results were bad, the median survival was around two years. In the 1990s something good happened; thalidomide

Read More
crossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram